Fundraising Fox
/Companies
Sign in

Creyon

3 known investors

Find your way into Creyon

Each arrow is one introduction. Sign up to fill in the first one.

258 people can intro you to Matthew

Ask Kiersten Stead to introduce you to Matthew Levy

You →Kiersten · together at Creyon →Matthew

Sign up to find every way you can get introduced to Creyon

  • Your email: who you already know at Creyon, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Creyon team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides. The company's platform addresses limitations in tissue penetration and immunogenicity for central nervous system and other tissue-targeted applications.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

MLMatthew Levy
Matthew LevyCo-founderMatthew Levy is a nucleic acid and biochemist with over 20 years of experience in oligonucleotide therapeutics. He was an Associate Professor of Biochemistry at Albert Einstein College of Medicine, where he led a research laboratory focused on aptamer development and protein engineering, and subsequently served as VP of Discovery at Vitrisa Therapeutics before co-founding Creyon.

Investors · 3

Tenmilelisted by Tenmile
DCVC BioreportedPalo Alto

How we know: funding news · Not right? Tell us

Frequently asked questions

What does Creyon do?
Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides. The company's platform addresses limitations in tissue penetration and immunogenicity for central nervous system and other tissue-targeted applications.
Who founded Creyon?
Creyon was founded by Matthew Levy.
Who are Creyon's investors?
Creyon's investors include Lux Capital, Tenmile, DCVC Bio.